Page last updated: 2024-10-23

biperiden and Hemolysis

biperiden has been researched along with Hemolysis in 1 studies

Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schroeder, C1
Heider, H1
Hegenscheid, B1
Schöffel, M1
Bubovich, VI1
Rosenthal, HA1

Other Studies

1 other study available for biperiden and Hemolysis

ArticleYear
The anticholinergic anti-Parkinson drug Norakin selectively inhibits influenza virus replication.
    Antiviral research, 1985, Volume: Suppl 1

    Topics: Amantadine; Animals; Antiviral Agents; Biperiden; Cell Line; Chick Embryo; Drug Interactions; Drug R

1985